[HTML] springer.comFull View

[HTML][HTML] Protein degradation: expanding the toolbox to restrain cancer drug resistance

H Ming, B Li, J Jiang, S Qin, EC Nice, W He… - Journal of hematology & …, 2023 - Springer
Despite significant progress in clinical management, drug resistance remains a major
obstacle. Recent research based on protein degradation to restrain drug resistance has …
被引用次数：17 相关文章

Protein degradation: expanding the toolbox to restrain cancer drug resistance

H Ming, B Li, J Jiang, S Qin, EC Nice… - … of hematology & …, 2023 - pubmed.ncbi.nlm.nih.gov
Despite significant progress in clinical management, drug resistance remains a major
obstacle. Recent research based on protein degradation to restrain drug resistance has …
[HTML] biomedcentral.com

[HTML][HTML] Protein degradation: expanding the toolbox to restrain cancer drug resistance

H Ming, B Li, J Jiang, S Qin… - … of Hematology & …, 2023 - jhoonline.biomedcentral.com
Despite significant progress in clinical management, drug resistance remains a major
obstacle. Recent research based on protein degradation to restrain drug resistance has …

Protein degradation: expanding the toolbox to restrain cancer drug resistance

H Ming, B Li, J Jiang, S Qin, E Nice, W He… - … of Hematology & …, 2023 - europepmc.org
Despite significant progress in clinical management, drug resistance remains a major
obstacle. Recent research based on protein degradation to restrain drug resistance has …

Protein degradation: expanding the toolbox to restrain cancer drug resistance

M Hui, L Bowen, J Jiang, S Qin, EC Nice… - … of Hematology & …, 2023 - search.proquest.com
Despite significant progress in clinical management, drug resistance remains a major
obstacle. Recent research based on protein degradation to restrain drug resistance has …
[HTML] nih.gov

[HTML][HTML] Protein degradation: expanding the toolbox to restrain cancer drug resistance

H Ming, B Li, J Jiang, S Qin, EC Nice, W He… - … of Hematology & …, 2023 - ncbi.nlm.nih.gov
Despite significant progress in clinical management, drug resistance remains a major
obstacle. Recent research based on protein degradation to restrain drug resistance has …

Protein degradation: expanding the toolbox to restrain cancer drug resistance.

H Ming, B Li, J Jiang, S Qin, EC Nice… - … of Hematology & …, 2023 - search.ebscohost.com
Despite significant progress in clinical management, drug resistance remains a major
obstacle. Recent research based on protein degradation to restrain drug resistance has …
[PDF] d-nb.info

[PDF][PDF] Protein degradation: expanding the toolbox to restrain cancer drug resistance

H Ming, B Li, J Jiang, S Qin, EC Nice, W He, T Lang… - 2023 - d-nb.info
Despite significant progress in clinical management, drug resistance remains a major
obstacle. Recent research based on protein degradation to restrain drug resistance has …

Protein degradation: expanding the toolbox to restrain cancer drug resistance.

H Ming, B Li, J Jiang, S Qin, EC Nice, W He… - … of Hematology & …, 2023 - europepmc.org
Despite significant progress in clinical management, drug resistance remains a major
obstacle. Recent research based on protein degradation to restrain drug resistance has …
[PDF] biomedcentral.com

[PDF][PDF] Protein degradation: expanding the toolbox to restrain cancer drug resistance

H Ming, B Li, J Jiang, S Qin, EC Nice, W He, T Lang… - 2023 - jhoonline.biomedcentral.com
Despite significant progress in clinical management, drug resistance remains a major
obstacle. Recent research based on protein degradation to restrain drug resistance has …